AGL
AGL
NYSE · Health Care

Agilon Health Inc

$116.75
+1.09 (+0.94%)
Financial Highlights (FY 2026)
Revenue
6.31B
Net Income
-416,237,521
Gross Margin
-0.8%
Profit Margin
-6.6%
Rev Growth
+29.9%
D/E Ratio
0.28
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -0.8% -0.8% 43.9% 43.9%
Operating Margin -7.8% -7.0% 8.6% 8.3%
Profit Margin -6.6% -6.3% 9.6% 9.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.31B 4.86B 170.45M 148.34M
Gross Profit -47,955,320 -36,925,633 74.85M 65.15M
Operating Income -492,804,017 -341,513,525 14.58M 12.34M
Net Income -416,237,521 -288,452,890 16.30M 14.45M
Gross Margin -0.8% -0.8% 43.9% 43.9%
Operating Margin -7.8% -7.0% 8.6% 8.3%
Profit Margin -6.6% -6.3% 9.6% 9.7%
Rev Growth +29.9% +29.9% -0.7% +8.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 210.15M 210.15M 59.25M 69.48M
Total Equity 761.15M 761.15M 122.26M 119.87M
D/E Ratio 0.28 0.28 0.48 0.58
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -462,280,466 -338,158,499 19.19M 18.14M
Free Cash Flow — — 11.38M 13.59M